We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+20.24%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$32M
Cap. Flow
-$54.4M
Cap. Flow %
-25.19%
Top 10 Hldgs %
70.66%
Holding
99
New
11
Increased
15
Reduced
20
Closed
12

Top Buys

Rank Stock Value
1
COGT icon
Cogent Biosciences
COGT
+$2.87M
2
ALKS icon
Alkermes
ALKS
+$2.27M
3
MRSN
Mersana Therapeutics
MRSN
+$2.12M
4
TGTX icon
TG Therapeutics
TGTX
+$1.47M
5
BHVN icon
Biohaven
BHVN
+$1.37M

Top Sells

Rank Stock Value
1
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$17.4M
2
CLMT icon
Calumet Specialty Products
CLMT
+$11.7M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.96M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$5.54M
5
VRNA
Verona Pharma
VRNA
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 41.34%
2 Materials 20.5%
3 Financials 18.92%
4 Communication Services 13.33%
5 Technology 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
76
Danaher
DHR
$140B
$41.2K 0.02%
180
– –
BRSL
77
Brightstar Lottery PLC
BRSL
$1.94B
$38.7K 0.02%
2,500
– –
BX icon
78
Blackstone
BX
$107B
$32.4K 0.02%
210
– –
DOW icon
79
Dow Inc
DOW
$21B
$28.2K 0.01%
1,206
– –
TMO icon
80
Thermo Fisher Scientific
TMO
$213B
$26.1K 0.01%
45
– –
OXY icon
81
Occidental Petroleum
OXY
$54B
$23.6K 0.01%
663
– –
CRM icon
82
Salesforce
CRM
$149B
$20.4K 0.01%
77
– –
UNH icon
83
UnitedHealth
UNH
$390B
$18.8K 0.01%
57
– –
KD icon
84
Kyndryl
KD
$2.96B
$11.4K 0.01%
428
– –
STWD icon
85
Starwood Property Trust
STWD
$6.2B
$7.2K ﹤0.01%
400
– –
GEHC icon
86
GE HealthCare
GEHC
$28.8B
$4.1K ﹤0.01%
50
– –
WAB icon
87
Wabtec
WAB
$51.2B
$1.28K ﹤0.01%
6
– –
ABBV icon
88
AbbVie
ABBV
$471B
– –
-5,037
Closed -$1.17M
AVDL
89
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-363,000
Closed -$5.54M
BCRX icon
90
BioCryst Pharmaceuticals
BCRX
$2.46B
– –
-32,570
Closed -$247K
CSX icon
91
CSX Corp
CSX
$95.1B
– –
-70,000
Closed -$2.48M
DAR icon
92
CALL
Darling Ingredients
DAR
$9.33B
– –
-300,000
Closed -$9.26M
IWR icon
93
iShares Russell Mid-Cap ETF
IWR
$56.5B
– –
-695
Closed -$99K
LLY icon
94
Eli Lilly
LLY
$1.09T
– –
-300
Closed -$229K
LQDA icon
95
Liquidia Corp
LQDA
$7.67B
– –
-107,783
Closed -$2.45M
PRAX icon
96
Praxis Precision Medicines
PRAX
$8.2B
– –
-28,000
Closed -$1.48M
TTE icon
97
TotalEnergies
TTE
$186B
– –
-1,200
Closed -$71.6K
VRNA
98
DELISTED
Verona Pharma
VRNA
– –
-38,355
Closed -$4.09M
1 2 3
4

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q4 2025 Portfolio in Review

As of Q4 2025, David M. Knott Jr held 99 positions worth $216M, down 13% from $248M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

David M. Knott Jr withdrew a net $54.4M in Q4 2025, closing 12 positions and reducing 20 holdings. Its most notable exit was Avadel Pharmaceuticals, an estimated $5.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 35% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Cogent Biosciences worth $3.62M.

  • David M. Knott Jr's largest Q4 2025 buy was Cogent Biosciences: 102,000 shares worth $3.62M.
  • David M. Knott Jr added most to Alkermes in Q4 2025, an estimated $2.27M increase.
  • David M. Knott Jr's biggest Q4 2025 reduction was Janus Henderson AAA CLO ETF, cutting an estimated $17.4M.
  • David M. Knott Jr fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $5.54M.
  • David M. Knott Jr's ten largest holdings make up 71% of its $216M portfolio in Q4 2025.
  • David M. Knott Jr opened 11 new positions and closed 12 in Q4 2025.
  • David M. Knott Jr's portfolio value fell 13% quarter-over-quarter to $216M.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.